10,269 Shares in Bruker Corporation $BRKR Acquired by Fox Run Management L.L.C.

Key Points

• Fox Run Management L.L.C. acquired a new stake in Bruker Corporation, purchasing 10,269 shares valued at approximately $429,000 in the first quarter.
• Bruker Corporation reported a quarterly earnings miss, with $0.32 earnings per share, below analysts' expectations, and a revenue decrease of 0.4% year-over-year to $797.40 million.
• The company announced a quarterly dividend of $0.05 per share, with a dividend yield of 0.6%, to be paid on October 3rd.

Fox Run Management L.L.C. purchased a new stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 10,269 shares of the medical research company's stock, valued at approximately $429,000.

A number of other hedge funds also recently bought and sold shares of BRKR. Raymond James Financial Inc. purchased a new position in Bruker during the 4th quarter valued at about $661,000. Sterling Capital Management LLC increased its holdings in Bruker by 29.0% during the 4th quarter. Sterling Capital Management LLC now owns 3,514 shares of the medical research company's stock valued at $206,000 after purchasing an additional 791 shares during the period. Barclays PLC increased its holdings in Bruker by 58.2% during the 4th quarter. Barclays PLC now owns 88,086 shares of the medical research company's stock valued at $5,164,000 after purchasing an additional 32,401 shares during the period. GeoWealth Management LLC increased its holdings in Bruker by 1,093.9% during the 4th quarter. GeoWealth Management LLC now owns 2,137 shares of the medical research company's stock valued at $125,000 after purchasing an additional 1,958 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Bruker by 22.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,687,364 shares of the medical research company's stock valued at $98,914,000 after purchasing an additional 313,171 shares during the period. Hedge funds and other institutional investors own 79.52% of the company's stock.

Bruker Stock Up 5.1%

Bruker stock traded up $1.74 during trading hours on Friday, hitting $35.54. 1,939,915 shares of the stock traded hands, compared to its average volume of 2,454,770. The firm's 50-day moving average price is $38.53 and its two-hundred day moving average price is $41.19. The company has a current ratio of 1.61, a quick ratio of 0.70 and a debt-to-equity ratio of 1.31. The company has a market cap of $5.39 billion, a PE ratio of 68.35, a PEG ratio of 2.79 and a beta of 1.16. Bruker Corporation has a one year low of $30.00 and a one year high of $72.94.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm had revenue of $797.40 million for the quarter, compared to the consensus estimate of $811.17 million. During the same period in the previous year, the firm posted $0.52 earnings per share. The business's revenue was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, research analysts forecast that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 23rd. Bruker's payout ratio is currently 38.46%.

Insider Activity at Bruker

In related news, CEO Frank H. Laukien purchased 2,608 shares of the company's stock in a transaction dated Friday, June 6th. The shares were purchased at an average cost of $38.36 per share, with a total value of $100,042.88. Following the transaction, the chief executive officer directly owned 38,462,171 shares in the company, valued at $1,475,408,879.56. This trade represents a 0.01% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 27.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on BRKR. Bank of America reduced their price target on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Barclays reduced their price target on Bruker from $46.00 to $43.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Wells Fargo & Company reduced their price target on Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Citigroup cut their price objective on Bruker from $40.00 to $38.00 and set a "neutral" rating on the stock in a research report on Monday, August 4th. Finally, Jefferies Financial Group set a $60.00 price objective on Bruker and gave the company a "buy" rating in a research report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $51.30.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.